fool.com·Apr 13, 2026
The pharmaceutical sector, while known for its high-growth potential and risks, includes undervalued companies like Bristol Myers Squibb that offer high dividend yields and steady revenue, making them suitable for value investors.
Consider adding Bristol Myers Squibb (NYSE: BMY) to your portfolio as it presents a potential value investment opportunity in the pharmaceutical sector, offering an undervalued stock with high dividend yields and steady revenue generation.